AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

An Evaluation of Myopia Control Lenses on Wearing Experience in Myopic Children

RecruitingNAAges 6 Years - 12 YearsAllEssilor International
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The goal of this research study is to understand the wearing experience of A.M.L. series of lenses in myopic children. The main questions it aims to answer are: * How quickly and effectively children adapt to the A.M.L. series of lenses? * The proportion of children who adapted to the A.M.L. series of lenses within 4 to 6 days? 40 myopic children aged 6 to 12 years will be recruited as participants, and all of them will be wearing A.M.L. series of lenses. Participants will: * Wear A.M.L. series of lenses for a period of 2 weeks * Visit at day 4-6, week 1 and week 2.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Volunteer participant * Informed consent of parent/guardian and assent of participant * Age equal to or greater than 6 years and not older than 12 years at the time of signing informed consent and assent * Spherical equivalent refraction (SER) by cycloplegic autorefraction equal or less than -0.50 D and equal or greater than -4.75D with astigmatism not more than 2.00 D on both eye * Difference in SER (anisometropia) between two eyes should not exceed 1.50 D * Best corrected visual acuity (BCVA) better than or equal to +0.10 LogMAR in each eye * Be in good general health, based on the participant and the parent's/guardian's knowledge * Willingness and ability to participate in study and comply with all scheduled visits Exclusion Criteria: * History of Atropine, Orthokeratology, or Red Light treatment * Strabismus by cover test at near or distance wearing correction * Amblyopia * Any ocular or systemic condition known to affect refractive status (e.g. keratoconus, diabetes, Downs syndrome, or other developmental disorders, etc.) * Current use of ocular or systemic medications which, in the investigator's opinion, may significantly affect pupil size, accommodation or refractive state * History of ocular injury or surgery * Participation in any clinical study within 30 days of the Baseline visit * Study participants deemed inappropriate for the study by the investigator * The inherent ocular/systemic discomfort (dry eyes, visual fatigue, headaches, etc.) that may affect the evaluation of the study lens wearing experience, from the investigator's perspective
๐Ÿ’Š

What it tests

  • A.M.L. Series of Lenses
๐Ÿ“

Where

1 site
Shanghai Meishimeijing Ophthalmology Clinic Co., Ltd.
Shanghai, China
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy